Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies

Bladder cancer (BCa) is an endocrine-related tumour and the activation of androgen signalling pathways may promote bladder tumorigenesis. We summarized the available preclinical and clinical evidence on the implications of the manipulation of androgen signalling pathways on the outcomes of BCa thera...

Descripció completa

Dades bibliogràfiques

Autors principals:	Massimiliano Creta, Giuseppe Celentano, Luigi Napolitano, Roberto La Rocca, Marco Capece, Gianluigi Califano, Claudia Collà Ruvolo, Francesco Mangiapia, Simone Morra, Carmine Turco, Lorenzo Spirito, Ferdinando Fusco, Ciro Imbimbo, Vincenzo Mirone, Nicola Longo
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-02-01
Col·lecció:	Diagnostics
Matèries:	5 alpha reductase inhibitors androgen deprivation therapy androgen receptor bladder cancer
Accés en línia:	https://www.mdpi.com/2075-4418/11/2/351
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!